Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3. | Theranostics | 2019 | 31244930 | PubTator, text mining | PubMed |
| CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death. | Mol Carcinog | 2019 | 31237025 | PubTator, text mining | PubMed |
| Protein-Protein Interaction Network Analysis Reveals Several Diseases Highly Associated with Polycystic Ovarian Syndrome. | Int J Mol Sci | 2019 | 31216618 | PubTator, text mining | PubMed |
| Cytotoxic Mechanism for Silver Nanoparticles Based High-Content Cellomics and Transcriptome Sequencing. | J Biomed Nanotechnol | 2019 | 31196346 | PubTator, text mining | PubMed |
| The Methylene-Cycloalkylacetate (MCA) Scaffold in Terpenyl Compounds with Potential Pharmacological Activities. | Molecules | 2019 | 31195609 | PubTator, text mining | PubMed |
| Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency. | Cardiol Res Pract | 2019 | 31192005 | PubTator, text mining | PubMed |
| Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor. | Mol Oncol | 2019 | 31162796 | PubTator, text mining | PubMed |
| Time varying causal network reconstruction of a mouse cell cycle. | BMC Bioinformatics | 2019 | 31142274 | PubTator, text mining | PubMed |
| Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis. | Cancer Biol Med | 2019 | 31119055 | PubTator, text mining | PubMed |
| FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway. | Cancer Manag Res | 2019 | 31118796 | PubTator, text mining | PubMed |
| p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance. | Free Radic Biol Med | 2019 | 31100478 | PubTator, text mining | PubMed |
| Prediction of IER5 structure and function using a bioinformatics approach. | Mol Med Rep | 2019 | 31059029 | PubTator, text mining | PubMed |
| Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer. | Front Oncol | 2019 | 31024841 | PubTator, text mining | PubMed |
| Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7. | Int J Mol Med | 2019 | 31017268 | PubTator, text mining | PubMed |
| The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents. | Antioxidants (Basel) | 2019 | 31003534 | PubTator, text mining | PubMed |
| Anti-Herpetic, Anti-Dengue and Antineoplastic Activities of Simple and Heterocycle-Fused Derivatives of Terpenyl-1,4-Naphthoquinone and 1,4-Anthraquinone. | Molecules | 2019 | 30986933 | PubTator, text mining | PubMed |
| Mesothelium and Malignant Mesothelioma. | J Dev Biol | 2019 | 30965570 | PubTator, text mining | PubMed |
| Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment. | Int J Nanomedicine | 2019 | 30962686 | PubTator, text mining | PubMed |
| Protein kinase D1 induces G1-phase cell-cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25. | Prostate | 2019 | 30958903 | PubTator, text mining | PubMed |
| Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation. | Front Oncol | 2019 | 30941306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=40